UT Southwestern preventive cardiologist to receive the 2025 Chairman’s Award

Dr. Amit Khera to be honored at American Heart Association Scientific Sessions 2025

2025-10-08

(Press-News.org) Embargoed until 7 a.m. CT/8 a.m. ET, Wednesday, Oct. 8, 2025

DALLAS, Oct. 8, 2025 — Amit Khera, M.D., FAHA, director of preventive cardiology and clinical chief of cardiology at the University of Texas (UT) Southwestern Medical Center, will receive the 2025 Chairman’s Award at the American Heart Association’s Scientific Sessions. The meeting, to be held Nov. 7-10, 2025, in New Orleans, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science. Dr. Khera will receive the award during the Presidential Session on Sunday, Nov. 9, 2025.

In addition to his roles as director of preventive cardiology and clinical chief of cardiology, Dr. Khera is also a professor of medicine and co-director of the Familial Hypercholesterolemia Clinic at UT Southwestern Medical Center, as well as a professor of epidemiology at the Peter O’Donnell Jr. School of Public Health at UT Southwestern. In addition, he holds the Dallas Heart Ball Chair in Hypertension and Heart Disease.

“It’s an honor to recognize Dr. Amit Khera with the 2025 Chairman’s Award for his distinguished accomplishments and service to the American Heart Association,” said Lee A. Shapiro, J.D., the 2025-2026 volunteer chairperson of the National Board of Directors for the American Heart Association. “Amit is an exceptional volunteer leader who has made significant contributions to strengthen the Association at the national and local levels. Most notably, his tireless efforts reinforced and strengthened our annual Scientific Sessions when he served as chair in 2023 and in the Association’s Centennial year 2024, and as vice chair in 2021 and 2022. As chair of the Scientific Sessions Program Committee, he facilitated greater collaboration among the Association’s councils and committees to provide multidisciplinary educational content that would appeal to a broad range of health care professionals and scientists. Thank you for your remarkable leadership that has enhanced the Association and Scientific Sessions.”

Dr. Khera’s professional career has transformed the field of preventive cardiology, and he has earned acclaim for several groundbreaking clinical studies. He has made significant contributions to the area of cardiovascular risk assessment with several impactful observations from the Dallas Heart Study on applications of coronary artery calcium scanning. He was funded by NASA to develop the Astro-CHARM calculator which is currently used to screen astronauts for heart disease risks. Dr. Khera is committed to improving the care for those with familial hypercholesterolemia (FH) and is leading an innovative study evaluating using the blood donation system to screen blood donors for FH.

Dr. Khera attributes his clinical and research interests to his residency in Boston, when he cared for a 45-year-old man hospitalized for his seventh heart procedure. Caring for this patient through cycles of invasive interventions is what sparked Dr. Khera’s passion for the prevention of coronary artery disease, with a focus on risk assessment and risk factor modification in people with premature and family histories of cardiovascular disease. He has authored more than 250 peer-reviewed publications, including serving on the writing committee for the “2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.”

As a past volunteer president of the Association’s Dallas and Southwest Region Board of Directors, Dr. Khera drove local engagement and strategic impact across the cardiovascular community. Dr. Khera has been an integral member of the Association’s Cardiovascular Kidney-Metabolic (CKM) Health Scientific Advisory Group since 2022, an initiative to harmonize gaps in clinical care and establish a new roadmap for patients with CKM syndrome through prevention and management of existing disease. He is an associate editor for the Association’s flagship, peer-reviewed scientific journal Circulation.

“I am deeply humbled to receive this recognition from an organization that I hold in such high regard for making such a profound impact on cardiovascular disease for over 100 years,” said Dr. Khera. “Preventive cardiology has always been central to my work, and I’m proud to work in collaboration with the Association to improve cardiovascular health and advance scientific discovery.”

Dr. Khera earned an undergraduate degree in American history from the University of Pennsylvania and a medical degree from Baylor College of Medicine, where he served as class president and was inducted into the Alpha Omega Alpha Honor Medical Society. He completed an internal medicine residency at Brigham and Women’s Hospital, Harvard Medical School in Boston, followed by a fellowship in cardiology at UT Southwestern Medical Center. He furthered his scientific training with a master’s in epidemiology from the Harvard School of Public Health.

Dr. Khera founded the UT Southwestern Preventive Cardiology program in 2004. For 15 years, Dr. Khera led and shaped the Cardiology Fellowship Program at UT Southwestern, serving as both associate and program director, for which he won numerous teaching awards. He was named a Master of the American Society for Preventive Cardiology in 2023, and he is a member of the Association of University Cardiologists. Dr. Khera is an NIH-funded investigator and an associate editor for the American Journal of Preventive Cardiology, which he helped to found in 2020. Dr. Khera is past president of the American Society for Preventive Cardiology and is an active member of other professional organizations, including the Texas Medical Association and the American College of Cardiology.

Additional Resources:

Multimedia is available on the right column of the release link. For more news at American Heart Association Scientific Sessions 2025, follow us on X @HeartNews, #AHA25 ###

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.

END

ELSE PRESS RELEASES FROM THIS DATE:

Slime mold metabolites are a promising, eco-friendly repellent of root-knot nematodes

2025-10-08

Root-knot nematodes (RKNs) are worm-like parasites of the genus Meloidogyne that are found in many parts of the world. They attack the roots of plants, causing them to wilt and eventually die. It is estimated that crops worth nearly USD 173 billion are lost every year due to RKN infestations. While chemical pesticides are effective in controlling RKNs, they also kill other microorganisms that are beneficial to plants, thereby reducing soil fertility. New, less toxic control methods are needed to prevent the loss of crops and soil fertility to RKNs. Cellular slime mold ...

Pathological mechanism of mechanosensitive cells driving the growth of keloids

2025-10-08

Keloids are raised, overgrown scars that can develop after skin injuries or surgery, often extending beyond the original wound boundaries. For many people, keloids are more than just a cosmetic concern; they often cause distressing symptoms such as chronic pain, itching, and restricted movement. While various treatment options exist, such as surgical removal, steroid injections, and radiation, keloids are notoriously difficult to manage, with recurrence rates reaching as high as 30%. Even after decades of study, it is still unclear why keloids grow uncontrollably, unlike hypertrophic scars. The current understanding is that an overproduction of extracellular ...

First large-scale Alzheimer disease study in brain tissue from African American donors implicates roles for many novel genes

2025-10-08

(Boston)—The prevalence of Alzheimer disease (AD) is approximately two times higher in African Americans (AA) compared to White/European-ancestry (EA) individuals living in the U.S. Some of this is due to social determinants of health such as disparities in health care access and quality of education, biases in testing and higher rates of AD risk factors such as cardiovascular disease and diabetes in those who identify as African American. Although many studies have examined differences in gene expression (measure of the amount of protein encoded by a gene) in brain tissue from AD cases and controls in EA or mixed ancestry ...

In a nasal spray, gold “nanoparticles” deliver a targeted treatment to the brain. A potentially revolutionary approach to mental disorders and neurodegenerative diseases already has a patent

2025-10-08

In the form of a ‘nasal spray’, tiny gold particles act as carriers, delivering a treatment directly to the brain: developed by scientists at the Università Cattolica Rome campus/Fondazione Policlinico Universitario A. Gemelli IRCCS, a new nanotechnological device for the treatment and prevention of neuropsychiatric and neurodegenerative diseases. These are lithium-loaded gold nanoparticles (lithium is already in clinical use for manic-depressive syndrome, but in oral formulation, not free from side effects) to combat neuropsychiatric diseases such as bipolar disorder, neurodegenerative diseases such as Alzheimer's disease, and brain infections such as those caused ...

Current and recommended diets in the USA have embedded forced labor risk

2025-10-08

Many Americans choose food based on cost and nutrition, but personal values, such as animal welfare and environmental concerns, also shape what ends up on our plates. Now, researchers at the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University and the University of Nottingham Rights Lab and School of Geography have measured the risk of forced labor behind ingredients in recommended U.S. diets. By showing when healthy eating may come at the expense of exploited workers, the findings ...

AI breakthrough helps astronomers spot cosmic events with just a handful of examples

2025-10-08

A new study co-led by the University of Oxford and Google Cloud has shown how general-purpose AI can accurately classify real changes in the night sky — such as an exploding star, a black hole tearing apart a passing star, a fast-moving asteroid, or a brief stellar flare from a compact star system — and explain its reasoning, without the need for complex training. Published today (8 October) in Nature Astronomy, the study by researchers from the University of Oxford, Google Cloud, and Radboud University demonstrates that a general-purpose ...

New vaccine shows promise against typhoid and invasive salmonella in first human trial

2025-10-08

Baltimore, MD — October 8, 2025 — Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical trial of a novel vaccine designed to protect against both typhoid fever and invasive non-typhoidal Salmonella--two major causes of illness and death among children in sub-Saharan Africa. Results were published today in the journal Nature Medicine. The investigational Trivalent Salmonella Conjugate Vaccine (TSCV) includes sugar molecules taken from the outer coating of the Salmonella typhi bacteria that cause typhoid and ...

Engineered “natural killer” cells could help fight cancer

2025-10-08

CAMBRIDGE, MA -- One of the newest weapons that scientists have developed against cancer is a type of engineered immune cell known as CAR-NK (natural killer) cells. Similar to CAR-T cells, these cells can be programmed to attack cancer cells. MIT and Harvard Medical School researchers have now come up with a new way to engineer CAR-NK cells that makes them much less likely to be rejected by the patient’s immune system, which is a common drawback of this type of treatment. The new advance may also make it easier to develop “off-the-shelf” ...

New 3D printing method ‘grows’ ultra-strong materials

2025-10-08

Vat photopolymerization is a 3D printing technique in which a light-sensitive resin is poured into a vat, and then selectively hardened into a desired shape using a laser or UV light. But this process is mostly used only with light-sensitive polymers, which limits its range of useful applications. While some 3D printing methods have been developed to convert these printed polymers into tougher metals and ceramics, Daryl Yee, head of the Laboratory for the Chemistry of Materials and Manufacturing in EPFL’s School of Engineering, explains that materials produced with these techniques suffer from serious structural setbacks. “These materials tend to be ...

Lizard genetics provide new perspective on evolution

2025-10-08

Some colourful lizards and a mathematical formula from the finance sector have been used to build a new framework to model evolution. Developed by Dr Simone Blomberg from The University of Queensland’s School of the Environment, it is the first mathematical model to combine short-term natural selection (microevolution) with the way species evolve over millions of years (macroevolution). “There has been a big debate about whether microevolution can explain all of macroevolution,” Dr Blomberg said. “We ...

First large-scale Alzheimer disease study in brain tissue from African American donors implicates roles for many novel genes

In a nasal spray, gold “nanoparticles” deliver a targeted treatment to the brain. A potentially revolutionary approach to mental disorders and neurodegenerative diseases already has a patent

UT Southwestern preventive cardiologist to receive the 2025 Chairman’s Award

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: